CN1220143A - 新鲜全胎盘粉胶囊的制作方法 - Google Patents
新鲜全胎盘粉胶囊的制作方法 Download PDFInfo
- Publication number
- CN1220143A CN1220143A CN97106784A CN97106784A CN1220143A CN 1220143 A CN1220143 A CN 1220143A CN 97106784 A CN97106784 A CN 97106784A CN 97106784 A CN97106784 A CN 97106784A CN 1220143 A CN1220143 A CN 1220143A
- Authority
- CN
- China
- Prior art keywords
- placenta hominis
- fresh
- powder capsule
- fresh full
- full
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002826 placenta Anatomy 0.000 title claims abstract description 34
- 239000000843 powder Substances 0.000 title claims abstract description 19
- 239000002775 capsule Substances 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 4
- 239000008280 blood Substances 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 13
- 230000003169 placental effect Effects 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 210000003954 umbilical cord Anatomy 0.000 claims description 7
- 239000004744 fabric Substances 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 238000009924 canning Methods 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 102100024819 Prolactin Human genes 0.000 description 2
- 108010057464 Prolactin Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229940097325 prolactin Drugs 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- 102000016893 Amine Oxidase (Copper-Containing) Human genes 0.000 description 1
- 108010028700 Amine Oxidase (Copper-Containing) Proteins 0.000 description 1
- 206010002701 Anterior pituitary hypofunction Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 108091000069 Cystinyl Aminopeptidase Proteins 0.000 description 1
- 102000030900 Cystinyl aminopeptidase Human genes 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- 108010071289 Factor XIII Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 206010051458 Myometritis Diseases 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102000004576 Placental Lactogen Human genes 0.000 description 1
- 108010003044 Placental Lactogen Proteins 0.000 description 1
- 239000000381 Placental Lactogen Substances 0.000 description 1
- 102100039419 Plasminogen activator inhibitor 2 Human genes 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000011923 Thyrotropin Human genes 0.000 description 1
- 108010061174 Thyrotropin Proteins 0.000 description 1
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 1
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 1
- 206010046764 Uterine atrophy Diseases 0.000 description 1
- 206010063146 Uterine hypoplasia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- ZESRJSPZRDMNHY-UHFFFAOYSA-N de-oxy corticosterone Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 ZESRJSPZRDMNHY-UHFFFAOYSA-N 0.000 description 1
- 229960003654 desoxycortone Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229940088592 immunologic factor Drugs 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- -1 kininase Proteins 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 206010043378 tetanus neonatorum Diseases 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229960000874 thyrotropin Drugs 0.000 description 1
- 230000001748 thyrotropin Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 108010065822 urokinase inhibitor Proteins 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种新鲜全胎盘粉胶囊的制作方法,(1)、将新鲜无污染全胎盘放入冷冻机内,在超低温状态下干燥粉碎成粉末状;(2)、将新鲜全胎盘粉罐入胶囊包装;(3)、将包装后的新鲜全胎盘粉胶囊进行辐射消毒得成品;用该方法制作的新鲜全胎盘粉胶囊,有效保存了新鲜全胎盘的全部营养物质和生物活性多肽,服用后有利于整体充分吸收,不含任何添加剂,是一种纯天然产品。
Description
本发明涉及一种医药保健食品。
现有技术中,人胎盘入中药,作为补品之用,常将胎盘洗净后进行日晒或人工烘烤成干品,然后整只或磨成粉状后出售入药,这种传统的加工方法不但破坏了胎盘的营养成分,而且也比较麻烦,因此不能批量生产作为正式医药保健食品使用。
本发明的目的是:提供一种新鲜全胎盘粉胶囊的制作方法,用该方法制作的新鲜全胎盘粉胶囊,有效保存了新鲜全胎盘的全部营养物质和生物活性多肽,服用后有利于整体充分吸收,不含任何添加剂,是一种纯天然产品。
本发明的技术方案是:一种新鲜全胎盘粉胶囊的制作方法,包括下列步骤:
(1).将新鲜无污染全胎盘放入冷冻机内,在超低温状态下干燥粉碎成粉末状。
(2).将新鲜全胎盘粉罐入胶囊包装。
(3).将包装后的新鲜全胎盘粉胶囊进行幅射消毒得成品。
所述新鲜全胎盘包括胎盘、脐带和脐血。
新鲜全胎盘,即健康产妇分娩的胎盘,包括脐带、脐血,为天然医药保健品。
胎盘又名人胞、人胎、胞衣、混沌衣、混沌皮、混元丹、紫河车、杜河车,甘、咸、温入肺、肝、肾经,大补气血益精养液,乃滋补强减药,气味俱厚,治一切虚损劳伤、气血不足、精液亏管之症。
1.补肺止咳:用于肺肾阴亏,喘嗽咯血。
2.补血益气:用于妇女血气不足,不能生育,月经不调及体弱乳少。
3.补肾益精:用于肝肾不足,虚损劳伤,头晕健忘赢瘦,阳萎遗精,潮热盗汗。
人胞一物现临床主要用它为强壮药,用于久病体虚或体质衰弱,抵抗力差及某些慢性疾患如哮喘等症,都是取它大补气血的功效。
胎盘含有蛋白、糖、钙、维生素、免疫因子及女性激素、助孕酮、类固醇、促性腺激素、促肾上腺皮质激素等,有强壮滋补功能,能促乳腺、女性生殖器、卵巢发育,有免疫功能,能增强抵抗力,兼有抗过敏性疾患作用,临床用于治疗子宫发育不全、子宫萎缩、子宫肌炎、机能性无月经、小卵巢囊肿、子宫出血、缺乳等疾患,有显著疗效,对于肺结核、吐血、咯血、支气管哮喘、贫血也有良好的效果,对血脉性肝硬化腹水及血吸虫早期肝硬化腹水也有一定的疗效。还可用于产后脑垂体前叶功能减退。
胎盘的成份较复杂,胎盘球蛋白制品中含有多种抗体,在临床上长期专用于被动免疫,人胎盘中还含有干扰素,有抑制多种病毒对人细胞的作用,以及含有能抑制流感病毒的巨球蛋白,称β-抑制因子,胎盘含有与血液凝固有关的成分,其中有类似凝血因子的纤维蛋白稳定因子、尿激酶抑制物和纤维蛋白溶解酶元活化物,人胎盘中含有的激素有:促性腺激素A和B、催乳素、促甲状腺激素、催产素样物质,各种甾体激素如雌酮、雌二醇、雌三醇、孕甾酮、雄甾酮、去氧皮质甾酮、11-去氧皮质甾酮、可的松、17-羟皮质甾酮,人胎盘催乳素与人垂体生长激素的化学结构上相关,有免疫交叉反应,也称催乳素-生长激素。人胎盘中含有多种有应用价值的酶,如溶菌酶、激肽酶、组胺酶、催产素酶等,另含有红细胞生长素,磷脂、多种多糖。
脐带又名坎气,甘成温,入心肺三经,益肾纳气,治虚劳赢弱,气血不足,肾虚喘咳。人胞上的脐带,介毒药,治小儿脐风,惊痫,气喘等症,对麻疹有抗毒免疫力,据日本皇汉医学专家之研究,谓胎盘上的脐带能治胃癌、肠癌、子宫癌,具有抗癌作用。
脐血据现代医学研究,具有增强免疫功能,治疗白血病等癌症。
本发明的优点是:有效保存了新鲜全胎盘的全部营养物质和生物活性多肽,充填于胶囊,有利于整体充分吸收,不含任何添加剂,是一种纯天然产品。
下面结合实施例对本发明作进一步的描述:
实施例:一种新鲜全胎盘粉胶囊的制作方法,包括下列步骤:
(1).将新鲜无污染全胎盘放入冷冻机内,在超低温状态下干燥粉碎成粉末状。
(2).将新鲜全胎盘粉罐入胶囊包装。
(3).将包装后的新鲜全胎盘粉胶囊进行幅射消毒得成品。所述新鲜全胎盘包括胎盘、脐带和脐血。用该方法制作的新鲜全胎盘粉胶囊,有效保存了新鲜全胎盘的全部营养物质和生物活性多肽,服用后有利于整体充分吸收,不含任何添加剂,是一种纯天然产品。
Claims (2)
1.一种新鲜全胎盘粉胶囊的制作方法,其特征在于包括下列步骤:
(1)将新鲜无污染全胎盘放入冷冻机内,在超低温状态下干燥粉碎成粉末状。
(2)将新鲜全胎盘粉罐入胶囊包装。
(3)将包装后的新鲜全胎盘粉胶囊进行幅射消毒得成品。
2.根据权利要求1所述的新鲜全胎盘粉胶囊的制作方法,其特征在于:所述新鲜全胎盘包括胎盘、脐带和脐血。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97106784A CN1220143A (zh) | 1997-12-16 | 1997-12-16 | 新鲜全胎盘粉胶囊的制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97106784A CN1220143A (zh) | 1997-12-16 | 1997-12-16 | 新鲜全胎盘粉胶囊的制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1220143A true CN1220143A (zh) | 1999-06-23 |
Family
ID=5168995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97106784A Pending CN1220143A (zh) | 1997-12-16 | 1997-12-16 | 新鲜全胎盘粉胶囊的制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1220143A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873544A (zh) * | 2014-10-14 | 2015-09-02 | 磐安县道地磐药中药研究所 | 一种羊胎盘纯粉及其制备方法和应用 |
CN107296271A (zh) * | 2017-07-11 | 2017-10-27 | 江苏希瑞干细胞技术有限公司 | 一种胎盘胶囊及其制备方法 |
CN107549657A (zh) * | 2016-06-30 | 2018-01-09 | 贺兴荣 | 羊胎盘胶囊及其制备方法 |
-
1997
- 1997-12-16 CN CN97106784A patent/CN1220143A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104873544A (zh) * | 2014-10-14 | 2015-09-02 | 磐安县道地磐药中药研究所 | 一种羊胎盘纯粉及其制备方法和应用 |
CN107549657A (zh) * | 2016-06-30 | 2018-01-09 | 贺兴荣 | 羊胎盘胶囊及其制备方法 |
CN107296271A (zh) * | 2017-07-11 | 2017-10-27 | 江苏希瑞干细胞技术有限公司 | 一种胎盘胶囊及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102090639B (zh) | 一种海参阿胶多肽营养制品及其制备方法 | |
CN108904784A (zh) | 一种牛骨胶原蛋白肽组合物及其制备方法 | |
CN109170475A (zh) | 一种具有调节人体平衡的sod固体饮料及其制备方法 | |
CN1220143A (zh) | 新鲜全胎盘粉胶囊的制作方法 | |
CN102172288A (zh) | 骨钙蛋白面条及其制作方法 | |
CN105168941A (zh) | 一种促进剖腹产伤口愈合的中药制剂及其制备方法 | |
CN109497563A (zh) | 白癜风专用型临床营养配方及其制备方法 | |
CN109010599A (zh) | 一种补气养血的固元膏及其制备方法 | |
CN1329908A (zh) | 一种康复丸及其制作方法 | |
CN101618087A (zh) | 一种具有改善更年期功能的保健食品 | |
CN106987511A (zh) | 一种基于高压脉冲电场技术的鹿血酒制备方法 | |
CN108402459B (zh) | 乌鳢乌鸡本草组合物及其制备方法和应用 | |
CN113349380A (zh) | 一种含牡蛎复合肽肾功能改善剂及其制备方法 | |
CN104873541B (zh) | 鹿血晶的新晶态及其制法 | |
CN108578531A (zh) | 肠癌康复液及其生产工艺 | |
CN105833020A (zh) | 一种促进术后创面愈合的外用护理药物组合物 | |
CN101632707A (zh) | 一种鹿胎膏及其制备方法 | |
CN106109830A (zh) | 一种预防和治疗月子病的中药组合物 | |
CN1180714C (zh) | 一种滋补保健品及其制备方法 | |
CN112998268A (zh) | 一种可以抑制肿瘤及增强免疫力的人参皂苷的加工方法 | |
CN111587995A (zh) | 一种基于羊头制备的孕妇用食品及其加工工艺 | |
CN105639007A (zh) | 一种补益气血保健茶及其制备方法 | |
CN111643535A (zh) | 一种秘制培元固本散及其配制方法 | |
CN110403195A (zh) | 一种调理冠心病的功能性食品及其制备方法 | |
CN110897160A (zh) | 一种蛹虫草龟鹿蛋白肽口服液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |